MedPath
HSA Approval

PMS-NYSTATIN SUSPENSION 500,000 u/5 ml

SIN05499P

PMS-NYSTATIN SUSPENSION 500,000 u/5 ml

PMS-NYSTATIN SUSPENSION 500,000 u/5 ml

February 22, 1991

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMEDICELL PHARMACEUTICAL (S) PTE. LTD.
Licence HolderMEDICELL PHARMACEUTICAL (S) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SUSPENSION

ORAL

Medical Information

A07AA02

nystatin

Manufacturer Information

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Pendopharm

Halo Pharmaceutical Canada Inc.

Active Ingredients

NYSTATIN

500000 u/5 ml

Nystatin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.